• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氧基聚乙二醇-红细胞生成素β(CERA,Mircera™)和红细胞生成素 δ(Dynepo™)单剂给药对等电点红细胞生成素谱和血液学参数的影响。

Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.

机构信息

Norwegian Doping Control Laboratory, Oslo University Hospital, 0586 Oslo, Norway.

出版信息

Drug Test Anal. 2011 May;3(5):291-9. doi: 10.1002/dta.270. Epub 2011 Mar 9.

DOI:10.1002/dta.270
PMID:21387570
Abstract

Erythropoietin (EPO) has been misused in sports for many years due to its performance-enhancing effect. In the last decade, detection of abuse has been possible with isoelectric focusing (IEF) based on the different isoform profiles of endogenous and recombinant EPO. The release of new EPOs on the market, such as the recombinant erythropoietin epoetin delta (Dynepo™) and the chemically modified EPO, CERA (Mircera™) potentially represents analytical challenges to the fight against doping. This study set out to investigate the possibility of and the time window for detecting the administration of a single dose of Dynepo™ and CERA. Our results are in agreement with earlier findings that detection of Dynepo™ is best achieved by combining IEF with SDS-PAGE. Haematological parameters were monitored for possible effects due to the long half-life (130 hours) of CERA in blood. Interestingly, although several haematological parameters were significantly changed after the injection of CERA, the endogenous EPO signal was still present in all collected samples. Due to the long half-life and the large size of the CERA molecule (about 60 kDa), it was uncertain whether CERA would be excreted into urine in detectable amounts unless urine collection was preceded by strenuous physical exercise. We find that CERA can be detected in urine without prior exercise in several, but not all, subjects. CERA is nevertheless best detected in serum with regard to both probability and length of detection, in addition to stability in matrix over time.

摘要

促红细胞生成素(EPO)因其具有增强运动表现的功效,多年来一直被滥用于运动领域。在过去十年中,通过等电聚焦(IEF)技术,根据内源性和重组 EPO 的不同同工型特征,可以检测到 EPO 的滥用情况。市场上新出现的 EPO,如重组促红细胞生成素 EPO 变体(Dynepo™)和化学修饰的 EPO(CERA),可能会对反兴奋剂斗争带来分析上的挑战。本研究旨在探索检测单次给予 Dynepo™和 CERA 后的可能性和时间窗口。我们的研究结果与早期的研究结果一致,即通过 IEF 与 SDS-PAGE 联合使用可以更好地检测 Dynepo™。监测血液学参数是否因 CERA 在血液中的半衰期(130 小时)较长而受到影响。有趣的是,尽管在注射 CERA 后几个血液学参数发生了显著变化,但所有收集的样本中仍存在内源性 EPO 信号。由于 CERA 的半衰期长且分子较大(约 60 kDa),如果在收集尿液之前没有进行剧烈的体育锻炼,不确定 CERA 是否会以可检测的量排泄到尿液中。我们发现,在没有事先进行剧烈运动的情况下,CERA 可以在一些但不是所有受试者的尿液中被检测到。然而,就检测的可能性和持续时间以及基质稳定性而言,CERA 在血清中的检测效果最好。

相似文献

1
Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.甲氧基聚乙二醇-红细胞生成素β(CERA,Mircera™)和红细胞生成素 δ(Dynepo™)单剂给药对等电点红细胞生成素谱和血液学参数的影响。
Drug Test Anal. 2011 May;3(5):291-9. doi: 10.1002/dta.270. Epub 2011 Mar 9.
2
Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.唾液酸去除法提高 SDS-PAGE 分析尿液样本中重组红细胞生成素的检测。
Drug Test Anal. 2013 Nov-Dec;5(11-12):870-6. doi: 10.1002/dta.1494. Epub 2013 May 29.
3
SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.重组和内源性促红细胞生成素的 SDS-PAGE:该方法在兴奋剂控制中的应用的优缺点。
Drug Test Anal. 2009 Jan;1(1):43-50. doi: 10.1002/dta.10.
4
Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.静脉应用后生物类似依泊汀kappa 和其他重组促红细胞生成素的兴奋剂检测控制。
Drug Test Anal. 2011 Nov-Dec;3(11-12):798-805. doi: 10.1002/dta.369. Epub 2011 Oct 19.
5
Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.微剂量注射后,使用 EPO WGA MAIIA、IEF 和 SAR-PAGE 检测血液和尿液样本中的重组 EPO。
Drug Test Anal. 2013 Nov-Dec;5(11-12):861-9. doi: 10.1002/dta.1579.
6
[Determination methods for erythropoietin receptor activator in human urine].[人尿液中促红细胞生成素受体激活剂的测定方法]
Yao Xue Xue Bao. 2009 Jul;44(7):820-3.
7
New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.高水合状态后检测重组人促红细胞生成素微剂量兴奋剂的新见解。
Drug Test Anal. 2016 Nov;8(11-12):1119-1130. doi: 10.1002/dta.2004. Epub 2016 Jul 8.
8
A rapid and simple assay to determine pegylated erythropoietin in human serum.一种快速、简单的测定人血清中聚乙二醇化红细胞生成素的方法。
J Appl Physiol (1985). 2010 Apr;108(4):800-3. doi: 10.1152/japplphysiol.01102.2009. Epub 2010 Jan 21.
9
Defending Dynepo detection.捍卫达依泊汀检测。
Drug Test Anal. 2010 Nov-Dec;2(11-12):526-32. doi: 10.1002/dta.230. Epub 2010 Dec 1.
10
Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.LC-MS 法确证检测马血浆中的连续性促红细胞生成素受体激活剂和促红细胞生成素类似物用于兴奋剂检测。
Anal Chem. 2010 Nov 1;82(21):9074-81. doi: 10.1021/ac102031w. Epub 2010 Oct 14.

引用本文的文献

1
Altitude Pre-Acclimatization with an Erythropoiesis-Stimulating Agent.使用促红细胞生成剂进行海拔预适应
Eur J Case Rep Intern Med. 2023 Mar 21;10(4):003792. doi: 10.12890/2023_003792. eCollection 2023.
2
A fast screening method for the detection of CERA in dried blood spots.一种用于检测干血斑中CERA的快速筛查方法。
Drug Test Anal. 2022 May;14(5):820-825. doi: 10.1002/dta.3142. Epub 2021 Aug 21.
3
Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.检测方法对自行车运动员促红细胞生成素(EPO)兴奋剂检测的灵敏度和特异性。
Drug Test Anal. 2019 Sep;11(9):1290-1301. doi: 10.1002/dta.2665. Epub 2019 Jul 17.